06-May-2024

Multimodal Imaging Market is Set for Exponential Growth, Expected to Cross USD 7.9 Billion by 2032 | CAGR of 6.1%

What is Multimodal Imaging ?

Multimodal imaging, the integration of various imaging techniques, is pivotal across numerous research fields like cancer, cardiovascular health, neurology, infectious diseases, immunology, and developmental biology. Both equipment manufacturers and researchers are avidly adopting this approach, resulting in the development of bi- or even tri-modal systems, reflecting the industry’s dedication to providing comprehensive solutions.

Multimodal Imaging Market Overview

According to the report, the global multimodal imaging industry generated $4.4 billion in 2022, and is anticipated to generate $7.9 billion by 2032, witnessing a CAGR of 6.1% from 2023 to 2032.

Request Sample of the Report on Multimodal Imaging Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/6621

What is Boosting Multimodal Imaging Market ?

The global multimodal imaging market is fueled by an increase in chronic diseases like cancer, advancements in diagnostic imaging modalities, and the expanding application of multimodal imaging systems. Nevertheless, market growth is hampered by the high cost of these systems. However, emerging markets offer promising growth opportunities in the foreseeable future.

E𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐃𝐨𝐰𝐧𝐭𝐮𝐫𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐑𝐞𝐜𝐞𝐬𝐬𝐢𝐨𝐧 𝐢𝐧 2023 𝐨𝐧 𝐭𝐡𝐞 𝐌𝐮𝐥𝐭𝐢𝐦𝐨𝐝𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭

During economic downturns such as recessions, both individuals and governments often tighten their budgets, potentially leading to reduced spending on healthcare services. This may hinder patients’ access to and affordability of multimodal imaging, potentially decreasing the demand for such imaging systems. Furthermore, healthcare facilities may experience constraints in their purchasing power, resulting in delayed or scaled-down investments in costly multimodal imaging technologies.

However, despite these challenges, the increasing prevalence of chronic diseases, advancements in technology, and growing awareness of the importance of early diagnosis and treatment could drive demand for specific types of multimodal imaging. This may lead to a moderate positive impact on certain segments of the multimodal imaging market, despite the overall global recession.

North America to maintain its dominance by 2032

In 2022, North America secured the largest market share in revenue, constituting nearly two-fifths of the global multimodal imaging market. This dominance is projected to persist during the forecast period, propelled by factors such as a robust healthcare system, the escalating prevalence of chronic diseases, technological advancements in imaging systems, and heightened awareness about early diagnosis and treatment.

Conversely, the Asia-Pacific region is anticipated to experience the fastest Compound Annual Growth Rate (CAGR) of 7.0% from 2023 to 2032. This growth trajectory is attributed to increasing awareness about early diagnosis and treatment, a rising incidence of chronic diseases like cancer, and a growing demand for advanced imaging systems.

Leading Market Players: –

GE Healthcare
Koninklijke Philips N.V.,
Canon Inc.
Siemens
Topcon Corporation
Bruker Corporation
Spectrum Dynamics Medical
Mediso Ltd.
MR Solutions
Neusoft Corporation

Recent Product Approval in the Multimodal Imaging Market

In December 2020, Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for its premium digital SPECT/ 64-sliceCT scanner, VERITON-CT64. VERITON-CT64 is designed for both, total body and organ-focused, hybrid imaging with shorter scan times, at lower injected activity when compared to current analog dual-detector technology.

Drive Your Business Growth Strategy: Purchase the Report for Key Insights:

Recent Expansion in the Multimodal Imaging Market

In April 2023, Siemens Healthineers expands its manufacturing base in India, inaugurates MRI facility at Bengaluru, under the Government of India’s PLI scheme. The company is dedicated to manufacturing Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) devices.

Recent Acquisitions in the Multimodal Imaging Market

In July 2021, Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.
In April 2022, Mediso Ltd announced the acquisition of Bartec Technologies Ltd, a UK based company specialized in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories. The acquisition strengthens market position in the UK and Ireland. Financial details of the acquisition were not disclosed.

Recent Product Development in the Multimodal Imaging Market

In October 2022, Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore SPECT/CT configuration. This functionality is available in the new VERITON-CT 400 Series Digital SPECT/CT scanners, enabling total body, brain, heart, and other imaging applications.

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/6621

Key Findings of the Study

On the basis of technology, the PET/CT systems segment was largest contributor to the market in 2022.
On the basis of application, oncology segment was largest contributor to the market in 2022.
On the basis of end user, the hospitals segment was largest contributor to the market in 2022.
Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Other Trending Reports in Life Science Domain

Hematology Diagnostics Market https://www.alliedmarketresearch.com/hematology-diagnostics-market-A10991

Surgical Drapes Market https://www.alliedmarketresearch.com/surgical-drapes-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int’l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Editor Details

Company:
- The Wire Times

Last Updated: 06-May-2024